|
Video: What is a Stock Split?
|
|
Shuttle Pharmaceuticals Holdings is a clinical stage pharmaceutical company utilizing its proprietary technology to develop therapies designed to cure cancers. Co. is developing a pipeline of products designed to address limitations of the existing cancer therapies as well as to extend to the new applications of radiation therapy (RT). Co.'s product candidates include Ropidoxuridine (IPdR), Extended Bio-availability IPdR, and a platform of histone deacetylase inhibitors (SP-1-161, SP-2-225 and SP-1-303). IPdR is Co.'s primary candidate radiation sensitizer for use in combination with RT to treat brain tumors (glioblastoma) and sarcomas. According to our SHPH split history records, Shuttle Pharmaceuticals Holdings has had 2 splits. | |
|
Shuttle Pharmaceuticals Holdings (SHPH) has 2 splits in our SHPH split history database. The first split for SHPH took place on June 23, 1999. This was a 1 for 20
reverse split, meaning for each 20
shares of SHPH owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split. SHPH's second split took place on February 01, 2000. This was a 1 for 50
reverse split, meaning for each 50
shares of SHPH owned pre-split, the shareholder now owned 1 share. For example, a 50 share position pre-split, became a 1 share position following the split.
When a company such as Shuttle Pharmaceuticals Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SHPH split history from start to finish, an original position size of 1000 shares would have turned into 1 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Shuttle Pharmaceuticals Holdings shares, starting with a $10,000 purchase of SHPH, presented on a split-history-adjusted basis factoring in the complete SHPH split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/01/2022 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$52.40 |
|
End price/share: |
$0.39 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.27% |
|
Average Annual Total Return: |
-94.89% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$73.49 |
|
Years: |
1.65 |
|
|
|
Date |
Ratio |
06/23/1999 | 1 for 20
| 02/01/2000 | 1 for 50
|
|
|